Compare JBS N.V. Class A Common Shares (JBS) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JBS N.V. Class A Common Shares vs Rocket Lab USA Inc — how do they compare? JBS N.V. Class A Common Shares trades at $13 (market cap $13.96B), while Rocket Lab USA Inc trades at $53.8 (market cap $37.84B). The key difference: Rocket Lab USA Inc is far larger — about 2.7× JBS N.V. Class A Common Shares's market cap, and JBS N.V. Class A Common Shares pays a 10.31% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and Rocket Lab USA Inc for 29 Days on average.
| JBS | RKLB | |
|---|---|---|
Market Cap | $13.96B | $37.84B |
Volume | 5,326,589 | 24,121,394 |
Sector | Consumer Staples | Industrials |
52-Week High | $18.42 | $150.23 |
52-Week Low | $10.86 | $39.48 |
Typical Hold Time | 0 Days | 29 Days |
Enterprise Value | $34.93B | $35.67B |
Dividend Yield | 10.31% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
Rocket Lab (RKLB) trades at $64.22, down 2.27% today, amid bearish technical signals despite strong analyst support. The company recently secured its largest-ever commercial Electron deal with Synspective for 20 launches, boosting its backlog past 100 missions. Financially, RKLB shows robust revenue growth ($602M in 2025, $769M projected for 2026) but remains unprofitable with a net income margin of -21.51%. Valuation metrics appear elevated with a P/S ratio of 48.79.
The outlook balances significant growth potential from a expanding launch backlog against persistent profitability challenges and competitive threats from SpaceX. Analyst consensus is strongly bullish with a $107 price target, but investors face risks from cash burn, execution hurdles, and high valuation multiples. The stock's near-term direction will hinge on Neutron rocket development and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JBS N.V. Class A Common Shares
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
